Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liver carcinoma
|
769 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.720 | 1.000 | 2 | 2011 | 2011 | |||||
Breast Carcinoma
|
2145 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.020 | 1.000 | 2 | 2008 | 2008 | |||||
Cutaneous Melanoma
|
58 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.020 | 1.000 | 2 | 2013 | 2016 | |||||
Malignant neoplasm of breast
|
2154 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.020 | 1.000 | 2 | 2008 | 2008 | |||||
melanoma
|
352 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.020 | 1.000 | 2 | 2013 | 2016 | |||||
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C
|
24 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.020 | 1.000 | 2 | 2013 | 2016 | |||||
Xeroderma pigmentosum, group F
|
23 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.020 | 1.000 | 2 | 2013 | 2016 | |||||
Acute pancreatitis
|
51 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Anaplastic thyroid carcinoma
|
16 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Carcinoma of lung
|
995 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||
Cutaneous Mastocytosis
|
13 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Diffuse Large B-Cell Lymphoma
|
109 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Esophageal carcinoma
|
170 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Esophageal Neoplasms
|
160 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Malignant neoplasm of esophagus
|
169 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Malignant neoplasm of lung
|
1000 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||
Peripheral T-Cell Lymphoma
|
10 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Primary malignant neoplasm of lung
|
981 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||
Sporadic Breast Carcinoma
|
45 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2004 | 2004 |